solid malignancies
Showing 1 - 14 of 14
Solid Malignancies Trial (Tisotumab Vedotin)
Not yet recruiting
- Solid Malignancies
- Tisotumab Vedotin
- (no location specified)
May 9, 2023
Solid Malignancies Trial in Canada (durvalumab, tremelimumab)
Active, not recruiting
- Solid Malignancies
-
Calgary, Alberta, Canada
- +6 more
Jan 24, 2022
Hepatocellular Carcinoma (HCC), Solid Malignancies Trial in Worldwide (FGF401, PDR001)
Completed
- Hepatocellular Carcinoma (HCC)
- Solid Malignancies
- FGF401
- PDR001
-
Los Angeles, California
- +26 more
Nov 21, 2020
Solid Malignancies, Metastatic Castrate-resistant Prostate Cancer Trial in Madison (axitinib)
Completed
- Solid Malignancies
- Metastatic Castrate-resistant Prostate Cancer
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Nov 15, 2019
Solid Malignancies Trial in Manchester ([14C]AZD2014, Multiple dose AZD2014, Fulvestrant)
Completed
- Solid Malignancies
- [14C]AZD2014
- +3 more
-
Manchester, United KingdomResearch Site
Jan 25, 2019
Solid Malignancies Trial in Lexington (7-t-butyldimethylsilyl-10-hydroxycamptothecin)
Completed
- Solid Malignancies
-
Lexington, KentuckyMarkey Cancer Center, University of Kentucky
Aug 12, 2013
Solid Malignancies Trial in Clermont-Ferrand (Pegfilgrastim (Neulasta, Amgen))
Unknown status
- Solid Malignancies
- Pegfilgrastim (Neulasta, Amgen)
-
Clermont-Ferrand, FranceCHU
Jan 18, 2011
Solid Malignancies Trial in Boston, Providence (Gimatecan® (ST-1481))
Completed
- Solid Malignancies
- Gimatecan® (ST-1481)
-
Boston, Massachusetts
- +2 more
Jun 2, 2009
Solid Malignancies Trial (Pegfilgrastim (drug))
Terminated
- Solid Malignancies
- Pegfilgrastim (drug)
- (no location specified)
Jun 12, 2008